PO.TB04.05 · 肿瘤生物学

Tissue-engineered organ-specific cancer metastasis model for cancer research

海报缩略图:Tissue-engineered organ-specific cancer metastasis model for cancer research
编号 739 展板 9 时间 4/19 02:00–05:00 区域 Section 30 主讲 Yi Yin, MD;PhD
分会场 Noninvasive Imaging and Analysis of Animal and Tissue Models
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Yi Yin1, Andrew Z. Wang2

1Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX,2University of Texas Southwestern Medical Center, Dallas, TX

摘要 Abstract

Understanding the biology of cancer metastasis is crucial for developing more effective treatments in oncology. A significant challenge in this area has been the lack of cancer models that accurately reflect the biology of metastasis, especially regarding organ-specificity, which is a key feature of cancer spread. This creates a strong unmet need for new models that can mimic the organ-specific dynamics of tumor spread. Our research group has been utilizing tissue engineering techniques to develop in vitro models of cancer metastasis. We hypothesize that decellularized tissues can effectively replicate the organ microenvironment associated with metastatic processes, serving as platforms for tumor cell growth. We had previously reported the use of decellularized liver and lung tissue as strata for tumor metastasis modeling. In this study, we have expanded the model using a panel of decellularized tissues to study the “good soils” and “bad soils” of metastasis. In experiments using several cancer cell lines, we found that tumor cells can spontaneously cluster and form colonies on biomatrices derived from common metastatic sites, such as the liver and lungs, often referred to as “good soil.” Decellularized biomatrices from the upper and lower gastrointestinal tract, and pancreas can also recapitulate the “bad soil” of cancer metastasis. These findings underscore that our proposed model of cancer metastasis is a powerful tool for cancer biology research and has great potential for precision oncology.
利益披露 Disclosure
Y. Yin, None.

在会议检索中打开